DERL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.021000E-01
Normal-vs-Stage2
7.393000E-01
Normal-vs-Stage3
5.208600E-01
Normal-vs-Stage4
7.129600E-01
Stage1-vs-Stage2
5.407600E-01
Stage1-vs-Stage3
5.275000E-01
Stage1-vs-Stage4
5.958200E-01
Stage2-vs-Stage3
2.306600E-01
Stage2-vs-Stage4
9.199600E-01
Stage3-vs-Stage4
3.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.712200E-01
Normal-vs-AfricanAmerican
8.456800E-01
Normal-vs-Asian
8.267000E-01
Caucasian-vs-AfricanAmerican
9.148000E-01
Caucasian-vs-Asian
9.122000E-01
AfricanAmerican-vs-Asian
9.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.782000E-01
Normal-vs-Female
7.134200E-01
Male-vs-Female
9.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.098400E-01
Normal-vs-Age(41-60Yrs)
3.469600E-01
Normal-vs-Age(61-80Yrs)
9.086200E-01
Normal-vs-Age(81-100Yrs)
9.211800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.131900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.208400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.725800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.255940E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.670200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.381600E-01
Normal-vs-Daily Drinker
9.584800E-01
Normal-vs-Weekly Drinker
9.709200E-01
Normal-vs-Occasional Drinker
3.182400E-01
Normal-vs-Social Drinker
8.665800E-01
Non Drinker-vs-Daily Drinker
7.864600E-01
Non Drinker-vs-Weekly Drinker
8.346800E-01
Non Drinker-vs-Occasional Drinker
2.070200E-02
Non Drinker-vs-Social Drinker
6.876200E-01
Daily Drinker-vs-Weekly Drinker
9.782600E-01
Daily Drinker-vs-Occasional Drinker
6.468200E-02
Daily Drinker-vs-Social Drinker
9.119800E-01
Weekly Drinker-vs-Occasional Drinker
9.617700E-02
Weekly Drinker-vs-Social Drinker
8.913600E-01
Occasional Drinker-vs-Social Drinker
5.731600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.398400E-01
Normal-vs-Grade 2
7.525200E-01
Normal-vs-Grade 3
6.996800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.980800E-01
Grade 1-vs-Grade 3
2.184400E-01
Grade 1-vs-Grade 4
5.398400E-01
Grade 2-vs-Grade 3
2.746800E-01
Grade 2-vs-Grade 4
7.525200E-01
Grade 3-vs-Grade 4
6.996800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.498400E-01
Normal-vs-NonDiabetic
7.858000E-01
Diabetic-vs-NonDiabetic
8.050000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.071600E-01
Normal-vs-NoPancreatitis
7.718600E-01
Pancreatitis-vs-NoPancreatitis
7.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.700000E-01
Normal-vs-N1
7.342400E-01
N0-vs-N1
7.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.229000E-01
Normal-vs-TP53-NonMutant
9.921800E-01
TP53-Mutant-vs-TP53-NonMutant
4.556800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
